Search for: All records

Abstract Chronic wounds present significant therapeutic challenges due to prolonged inflammation and bacterial infections, impeding healing. Conventional medicinal dressings typically deliver a single drug with a fixed release profile and lack responsiveness to variations in wound size, nature, or severity. This study introduces an innovative microneedle (MN) patch designed with different microneedle geometries and capable of dual‐drug delivery to address irregular wounds and complex therapeutic requirements. Utilizing CO₂ laser lithography, microneedle molds are fabricated with diverse geometries by precisely controlling laser parameters such as speed, power, and focus, achieving needle heights ranging from 162 ± 30 µm to 1570 ± 40 µm. The patch facilitates simultaneous delivery of simvastatin (SIM) for anti‐inflammatory and tetracycline hydrochloride (TH) for antibacterial properties, targeting different skin depths. In vitro diffusion studies confirm geometry‐dependent drug release profiles, with SIM achieving controlled release over three days and TH exhibiting sustained release over four days. Biocompatibility assays confirmed safety and enhanced fibroblast migration is noted in wound‐healing studies. Antimicrobial testing reveals a 99.9% reduction in bacterial viability. This cost‐effective and scalable approach enables precise, localized delivery and customization of MN arrays to match various wound geometries, offering a versatile platform for personalized medicine and improved chronic wound management.